Huibi Cao

1.5k total citations
29 papers, 702 citations indexed

About

Huibi Cao is a scholar working on Molecular Biology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Huibi Cao has authored 29 papers receiving a total of 702 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 15 papers in Genetics and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Huibi Cao's work include Virus-based gene therapy research (15 papers), Energy Harvesting in Wireless Networks (6 papers) and RNA Interference and Gene Delivery (6 papers). Huibi Cao is often cited by papers focused on Virus-based gene therapy research (15 papers), Energy Harvesting in Wireless Networks (6 papers) and RNA Interference and Gene Delivery (6 papers). Huibi Cao collaborates with scholars based in Canada, China and France. Huibi Cao's co-authors include Jim Hu, Anik Girard-Globa, François Berthézène, Philippe Moulin, David R. Koehler, Rahul Kushwah, Jing Wu, Robert S. Molday, Allan L. Coates and Yiqian Zhang and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Human Molecular Genetics.

In The Last Decade

Huibi Cao

29 papers receiving 687 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huibi Cao Canada 15 361 217 156 136 82 29 702
Tze-Tze Liu Taiwan 17 459 1.3× 67 0.3× 61 0.4× 299 2.2× 118 1.4× 38 887
Jacob M. Jones United States 10 976 2.7× 20 0.1× 17 0.1× 78 0.6× 36 0.4× 24 1.1k
Dieter Rondas Belgium 15 316 0.9× 206 0.9× 27 0.2× 42 0.3× 10 0.1× 18 739
Afsoon Afshari Iran 10 281 0.8× 164 0.8× 16 0.1× 5 0.0× 74 0.9× 40 666
Guangjun Jing China 13 257 0.7× 72 0.3× 21 0.1× 23 0.2× 8 0.1× 22 643
Takeya Sato Japan 16 308 0.9× 115 0.5× 29 0.2× 14 0.1× 8 0.1× 51 707
Toyoko Ochiai Japan 14 280 0.8× 43 0.2× 35 0.2× 14 0.1× 27 0.3× 41 593
Astrid Pañeda Spain 15 337 0.9× 239 1.1× 10 0.1× 20 0.1× 324 4.0× 28 944
Simonetta Bandiera France 9 790 2.2× 36 0.2× 24 0.2× 26 0.2× 23 0.3× 14 1.1k

Countries citing papers authored by Huibi Cao

Since Specialization
Citations

This map shows the geographic impact of Huibi Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huibi Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huibi Cao more than expected).

Fields of papers citing papers by Huibi Cao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huibi Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huibi Cao. The network helps show where Huibi Cao may publish in the future.

Co-authorship network of co-authors of Huibi Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Huibi Cao. A scholar is included among the top collaborators of Huibi Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huibi Cao. Huibi Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cao, Huibi, Juntao Mai, Zhijie Li, et al.. (2021). Intranasal HD-Ad vaccine protects the upper and lower respiratory tracts of hACE2 mice against SARS-CoV-2. Cell & Bioscience. 11(1). 202–202. 11 indexed citations
2.
Cao, Huibi, Hong Ouyang, Onofrio Laselva, et al.. (2020). A helper-dependent adenoviral vector rescues CFTR to wild-type functional levels in cystic fibrosis epithelial cells harbouring class I mutations. European Respiratory Journal. 56(5). 2000205–2000205. 23 indexed citations
3.
Yang, Liang, et al.. (2019). In Vitro Validation of a CRISPR-Mediated CFTR Correction Strategy for Preclinical Translation in Pigs. Human Gene Therapy. 30(9). 1101–1116. 27 indexed citations
4.
Cao, Huibi, Hong Ouyang, Wan Ip, et al.. (2015). Testing gene therapy vectors in human primary nasal epithelial cultures. Molecular Therapy — Methods & Clinical Development. 2. 15034–15034. 15 indexed citations
5.
Cao, Huibi, et al.. (2014). Highly efficient retinal gene delivery with helper-dependent adenoviral vectors. Genes & Diseases. 1(2). 227–237. 7 indexed citations
6.
Munegowda, Manjunatha Ankathatti, et al.. (2014). Lung gene therapy—How to capture illumination from the light already present in the tunnel. Genes & Diseases. 1(1). 40–52. 14 indexed citations
7.
Cao, Huibi, Tiago Machuca, Jonathan Yeung, et al.. (2013). Efficient Gene Delivery to Pig Airway Epithelia and Submucosal Glands Using Helper-Dependent Adenoviral Vectors. Molecular Therapy — Nucleic Acids. 2. e127–e127. 34 indexed citations
8.
Chen, Bojiang, Youjuan Wang, Huibi Cao, et al.. (2012). Early Lung Cancer Detection Using the Self-Evaluation Scoring Questionnaire and Chest Digital Radiography: A 3-Year Follow-up Study in China. Journal of Digital Imaging. 26(1). 72–81. 3 indexed citations
9.
Cao, Huibi, Jing Wu, Robert S. Molday, et al.. (2011). Temporal and Tissue Specific Regulation of RP-Associated Splicing Factor Genes PRPF3, PRPF31 and PRPC8—Implications in the Pathogenesis of RP. PLoS ONE. 6(1). e15860–e15860. 42 indexed citations
10.
Chen, Bojiang, Huibi Cao, Dongmei Wang, et al.. (2011). Design and application of a self‐evaluation questionnaire for individuals at a high‐risk of lung cancer. Thoracic Cancer. 3(1). 60–67. 2 indexed citations
11.
Cao, Huibi, Robert S. Molday, & Jim Hu. (2011). Gene therapy: light is finally in the tunnel. Protein & Cell. 2(12). 973–989. 14 indexed citations
12.
Wu, Linda, Huibi Cao, Rui Guan, et al.. (2011). Subretinal gene delivery using helper-dependent adenoviral vectors. Cell & Bioscience. 1(1). 15–15. 9 indexed citations
13.
Yang, Tianyao, Huibi Cao, Benjamin H. Lee, et al.. (2010). Development of an inflammation‐inducible gene expression system using helper‐dependent adenoviral vectors. The Journal of Gene Medicine. 12(10). 832–839. 5 indexed citations
14.
Cao, Huibi, et al.. (2010). Readministration of helper-dependent adenoviral vectors to mouse airway mediated via transient immunosuppression. Gene Therapy. 18(2). 173–181. 29 indexed citations
15.
Hu, Jim, et al.. (2009). The Degeneration of Photoreceptor Cells in the Rp1 Form of Retinitis Pigmentosa Is Caused by a Dominant Mechanism. Investigative Ophthalmology & Visual Science. 50(13). 2285–2285. 1 indexed citations
16.
Kushwah, Rahul, Huibi Cao, & Jim Hu. (2008). Characterization of Pulmonary T Cell Response to Helper-Dependent Adenoviral Vectors following Intranasal Delivery. The Journal of Immunology. 180(6). 4098–4108. 21 indexed citations
17.
Cao, Huibi, et al.. (2007). Mutation in the splicing factor Hprp3p linked to retinitis pigmentosa impairs interactions within the U4/U6 snRNP complex. Human Molecular Genetics. 17(2). 225–239. 20 indexed citations
18.
Kushwah, Rahul, Jordan Oliver, Huibi Cao, & Jim Hu. (2007). Nacystelyn enhances adenoviral vector-mediated gene delivery to mouse airways. Gene Therapy. 14(16). 1243–1248. 28 indexed citations
19.
Cao, Huibi, David R. Koehler, & Jim Hu. (2004). Adenoviral Vectors for Gene Replacement Therapy. Viral Immunology. 17(3). 327–333. 74 indexed citations
20.
Cao, Huibi, Anik Girard-Globa, André Sérusclat, et al.. (1998). Lack of association between carotid intima-media thickness and paraoxonase gene polymorphism in non-insulin dependent diabetes mellitus. Atherosclerosis. 138(2). 361–366. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026